<DOC>
	<DOCNO>NCT01797198</DOCNO>
	<brief_summary>ASP3652 investigate novel treatment chronic pelvic pain . This two-part study investigate drug-drug potential ASP3652 . Part I study evaluates effect gemfibrozil twice daily single dose ASP3652 . Part 2 evaluates effect multiple dos ASP3652 twice daily single dose repaglinide . Subjects participate one part study may participate part .</brief_summary>
	<brief_title>A Study Assess Effect Multiple Doses Gemfribozil Single Dose ASP3652 , Assess Effects Multiple Doses ASP3652 Single Dose Repaglinide Body Healthy Subjects</brief_title>
	<detailed_description>Part 1 : On Day 1 , single dose ASP3652 administer . After wash-out period 3 day , bid ( twice daily ) dose gemfibrozil start Day 4 continue 7 day Day 10 . On Day 8 ( 5th day gemfibrozil administration ) , single dose ASP3652 administer one hour morning dose gemfibrozil . Part 2 : On Day 1 , single dose repaglinide administer . After wash-out period 3 day , bid dose ASP3652 start Day 4 continue 7 day Day 10 . On Day 8 ( 5th day ASP3652 administration ) , single dose repaglinide administer one hour morning dose ASP3652 .</detailed_description>
	<mesh_term>Gemfibrozil</mesh_term>
	<mesh_term>Repaglinide</mesh_term>
	<criteria>Subject white Caucasian origin . Body Mass Index equal 18.5 less 30.0 kg/m2 . Male subject must agree practice effective contraceptive method female sexual partner prevent pregnancy . Known suspected hypersensitivity ASP3652 , repaglinide and/or gemfibrozil , component formulation use . Any liver function test ( ALT , AST , Î³GT , TBL ALP ) upper limit normal . In case sample may repeat . Regular use inducer metabolism ( e.g . barbiturate , Rifampicin ) 3 month prior admission Clinical Unit .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>Phase I</keyword>
	<keyword>ASP3652</keyword>
	<keyword>Gemfibrozil</keyword>
	<keyword>Repaglinide</keyword>
	<keyword>Pharmacokinetics</keyword>
</DOC>